Hyundai Pharmaceutical Co., Ltd. (KRX: 004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,450.00
+5.00 (0.15%)
Nov 15, 2024, 3:30 PM KST
-11.20%
Market Cap 97.01B
Revenue (ttm) 108.14B
Net Income (ttm) 1.41B
Shares Out 27.68M
EPS (ttm) 60.34
PE Ratio 58.09
Forward PE n/a
Dividend 35.00 (1.01%)
Ex-Dividend Date n/a
Volume 145,935
Open 3,390.00
Previous Close 3,445.00
Day's Range 3,330.00 - 3,465.00
52-Week Range 3,330.00 - 6,620.00
Beta 0.54
Analysts n/a
Price Target n/a
Earnings Date n/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.